Treatment of Demodex Blepharitis
An overview of the current landscape of available treatment options for Demodex blepharitis is analyzed.
Source: ajmc.com
Titan Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Titan Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Titan Study Today - Breaking & Trending Today
Risk Factors and Mental Health Impact of Demodex Blepharitis
Dr. Yeu examines risk factors for Demodex blepharitis, including patients with diabetes and immunosuppression.
Source: ajmc.com
Differential Diagnosis: Key Features of Demodex Blepharitis
Factors that differentiate Demodex blepharitis apart from other lid margin and ocular surface diseases with overlapping signs and symptoms are examined.
Source: ajmc.com
Metastatic Hormone-Sensitive Prostate Cancer: Data from TITAN and PEACE-1
Key opinion leaders reflect on data from the TITAN and PEACE-1 clinical trials, respectively, in the setting of metastatic hormone-sensitive prostate cancer.
Source: onclive.com
Tarsus Pharmaceuticals, Inc. Presents New Saturn-1 Pivotal Trial Data and Titan Real-World Prevalence Study Results at ASCRS 2021
Tarsus Pharmaceuticals, Inc. Presents New Saturn-1 Pivotal Trial Data and Titan Real-World Prevalence Study Results at ASCRS 2021 Home / Top News / Tarsus Pharmaceuticals, Inc. Presents New Saturn-1 Pivotal Trial Data and Titan Real-World Prevalence Study Results at ASCRS 2021 Tarsus Pharmaceuticals, Inc. Presents New Saturn-1 Pivotal Trial Data and Titan Real-World Prevalence Study Results at ASCRS 2021 New Saturn-1 data demonstrated a strong patient responder rate with 95% of Demodex blepharitis patients treated with TP-03 achieving ≤0.5 mites per lash and 93% improving by at least one co...
Source: forextv.com